Investify Me

Latest IPO GMP

Highest estimated gain first

Millworks Technologies Limited

Closes 16 Jul 2026

Rs 400

120.8% gain

Live

Avience Biomedicals Limited

Closes 22 Jun 2026

Rs 145

69.7% gain

Live

KRATIKAL TECH LIMITED

Closes 02 Jul 2026

Rs 78

57.8% gain

Live

DEVSON CATALYST LIMITED

Closes 13 Jul 2026

Rs 45

38.1% gain

SBI Funds Management Limited

Closes 16 Jul 2026

Rs 111

19.3% gain

Live

Happy Steels Limited

Closes 13 Jul 2026

Rs 7

10.6% gain

Live

Twinkle Papers Limited

Closes 01 Jul 2026

Rs 2

2.9% gain

ALPINE TEXWORLD LIMITED

Closes 16 Jul 2026

Rs 9

1.9% gain

Live

Sampark India Logistics Limited

Closes 02 Jul 2026

Rs 0

0% gain

Live

Seemax Resources Limited

Closes 02 Jul 2026

Rs 0

0% gain

Live

Vinit Mobile Limited

Closes 02 Jul 2026

Rs 0

0% gain

Live

Adon Agro Commodities Limited

Closes 01 Jul 2026

Rs 0

0% gain

Live

Crazy Snacks Limited

Closes 30 Jun 2026

Rs 0

0% gain

Live

ATHARVA POLY-PLAST LIMITED

Closes 02 Jul 2026

Awaiting

GMP update

Live

Anubhav Plast Limited

Closes 23 Jun 2026

Awaiting

GMP update

Live

IC Electricals Company Limited

Closes 07 Jul 2026

Awaiting

GMP update

Live

IC Electricals Company Limited-Issue postponed

Closes 30 Jun 2026

Awaiting

GMP update

Live

JIVIAL INDUSTRIES LIMITED

Closes 25 Jun 2026

Awaiting

GMP update

Live

Laser Power and Infra Limited

Closes 13 Jul 2026

Awaiting

GMP update

Live

RIYAASAT LIFESTYLE LIMITED

Closes 25 Jun 2026

Awaiting

GMP update

Live

Shreedhar Spinners Limited

Closes 25 Jun 2026

Awaiting

GMP update

Live

Sri Priyanka Geo Commex Limited

Closes 29 Jun 2026

Awaiting

GMP update

Live

Sri Priyanka Geo Commex Limited-Issue Withdrawn

Closes 29 Jun 2026

Awaiting

GMP update

Live

Teja Engineering Industries Limited

Closes 02 Jul 2026

Awaiting

GMP update

View all

MAINBOARD / UPCOMING

SBI Funds Management Limited

Follow SBI Funds Management Limited IPO dates, price band, lot size, issue size, listing schedule, GMP trends, and Investify Score.

54/100

Opens

14 Jul 2026

Closes

16 Jul 2026

Price band

Rs 545 - Rs 574

Issue size

Not published

GMP trend

About SBI Funds Management Limited

63 55. Changes in tax laws or interpretation of tax laws could adversely affect the tax treatment of mutual fund investments and investor demand for our products. The tax treatment of mutual fund investments is a significant factor influencing investor decisions and product preferences. Currently, equity-oriented mutual fund schemes benefit from favourable tax treatment including long-term capital gains tax of 12.5% (plus applicable surcharge and cess) on gains exceeding INR 125,000 per annum for units held for more than one year, short-term capital gains tax of 20% (plus applicable surcharge and cess) for units held for one year or less, subject to satisfaction of prescribed conditions. Debt-oriented mutual fund schemes purchased up to 31st March 2023 are subject to capital gains tax at applicable slab rates for short-term gains (units held for up to 24 months for unlisted funds and up to 12 months for listed funds) and cess, and 12.5% (plus applicable surcharge and cess) for long-term gains (units held for more than 24 months for unlisted funds and more than 12 months for listed funds). Capital gains on specified mutual funds (i.e., funds having 65% or more allocation in debt and money market instruments or which invests 65% or more of its total proceeds in such specified mutual funds) acquired on or after April 1, 2023, shall be treated as short term capital gains irrespective of holding period and will be taxable at normal tax rates applicable to the investor. Funds other than equity-oriented funds and specified mutual funds (such as multi asset allocation funds or certain conservative hybrid funds or gold/silver funds) are subject to capital gains tax at applicable slab rates for short term gains (units held for up to 24 months for unlisted funds and up to 12 months for listed funds) plus applicable surcharge and cess, and at 12.5% (plus applicable surcharge and cess) for long term gains (units held for more than 24 months for unlisted funds and more than 12 months for listed funds). Any adverse changes in these tax provisions, including increases in capital gains tax rates, or changes in the definition of long- term versus short-term holding periods, could reduce the attractiveness of mutual fund investments and affect investor demand. Additionally, changes in tax treatment of competing investment products such as bank deposits, insurance products, or direct equity investments could affect the relative attractiveness of mutual funds. The government periodically reviews tax policies as part of budget exercises and tax reform initiatives, and there can be no assurance that future changes will not adversely affect mutual fund investments. Any material adverse changes in tax treatment could result in investor redemptions, reduced new inflows, and shifts in investor preferences across product categories, which could adversely affect our AUM, revenues, and profitability. 56. Global economic conditions, international capital flows, and foreign exchange rate fluctuations could adversely affect Indian capital markets and our business. Indian capital markets are increasingly integrated with global financial markets and are significantly influenced by global economic conditions, international capital flows, and foreign exchange rate movements. Foreign institutional investors and foreign portfolio investors play a significant role in Indian equity and debt markets, and their investment decisions are influenced by global factors including economic conditions in major economies, monetary policies of major central banks, global risk appetite, relative attractiveness of emerging markets versus developed markets, and geopolitical developments. Adverse global economic conditions, tightening of monetary policy by major central banks, strengthening of the US dollar, or increased global risk aversion could result in capital outflows from India, which could negatively impact Indian equity and debt markets and consequently affect our scheme performance and AUM. During 2025, foreign portfolio investors withdrew from Indian equities, the highest annual outflow on record, driven by elevated valuations in Indian markets relative to other emerging markets, subdued earnings visibility, tariff uncertainties affecting Indian exports, and shifts in global capital allocation favouring artificial intelligence and technology stocks in developed markets. The US Federal Reserve’s monetary policy stance, including interest rate decisions and quantitative tightening measures, significantly influences global capital flows. Any resumption of aggressive rate hikes by the Federal Reserve or other major central banks in response to persistent inflation could trigger further capital outflows from emerging markets including India. Additionally, significant depreciation of the Indian rupee against major currencies could result in imported inflation, current account pressures, and potential monetary policy tightening by the Reserve Bank of India, which could adversely affect economic growth and capital market performance. Conversely, significant appreciation of the rupee could affect export competitiveness and corporate earnings, particularly in sectors such as information technology and pharmaceuticals that derive substantial revenues from exports. Our schemes with international investments or our GIFT City funds serving international investors are also directly exposed to foreign exchange rate fluctuations. The rupee has experienced periods of significant volatility, and any sharp movements in either direction could affect scheme performance and investor sentiment. Global economic fragmentation, including the reshaping of supply chains, trade blocs, and investment flows in response to geopolitical tensions between major powers, could also affect India’s economic prospects and capital market performance. The shift in global manufacturing and investment patterns, while potentially benefiting India as companies seek alternatives to China, also creates uncertainty regarding the pace and sustainability of such shifts. Additionally, any global economic recession, financial crisis, or sovereign debt crisis in major economies could trigger risk-off sentiment and capital flight from emerging markets. The increasing correlation between global equity markets means that sharp declines in US, European, or Chinese 64 markets often result in corresponding declines in India

Objects of the issue

The objects of the Offer are to (i) carry out the Offer for Sale of up to 203,709,239 Equity Shares of face value of ₹1 each by the Promoter Selling Shareholders aggregating up to ₹ [●] million; and (ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, our Company expects that listing of the Equity Shares will enhance our visibility and brand image as well as provide a public market for the Equity Shares in India. Offer for Sale Each Promoter Selling Shareholder shall be entitled to its respective portion of the proceeds of the Offer for Sale, after deducting its respective portion of the Offer-related expenses and the relevant taxes thereon, in accordance with the terms of the Offer Agreement. For further details, see “- Offer-related expenses” on page 118. Each of the Promoter Selling Shareholders has, severally and not jointly, authorised its respective participation in the Offer for Sale to the extent of its respective portion of the Offered Shares, pursuant to their respective consent letters, as set out below. For details, see “The Offer” on page 72. Sr. Promoter Selling Aggregate number of Equity Shares being Date of corporate Date of consent letter No. Shareholder offered in the Offer for Sale approval/ authorisation 1. State Bank of India Up to 128,334,397 Equity Shares of face value November 6, 2025 and March 16, 2026 ₹1 each aggregating up to [●] million February 25, 2026 2. Amundi India Up to 75,374,842 Equity Shares of face value ₹1 March 3, 2026 March 18, 2026 and Holding each aggregating up to [●] million July 7, 2026 Total Up to 203,709,239 Equity Shares of face value ₹1 each aggregating up to [●] million Utilisation of the Offer Proceeds by the Promoter Selling Shareholders Our Company will not receive the Offer Proceeds and all the Offer Proceeds will be received by the Promoter Selling Shareholders after deduction of their respective portion of the Offer-related expenses and the relevant taxes thereon, to be borne by the respective Promoter Selling Shareholders. Offer-related Expenses The Offer expenses are estimated to be approximately ₹ [●] million. The expenses in relation to this Offer include, among others, listing fees, filing fees, book building fees and other charges, fees and expenses of the SEBI, the Stock Exchanges, the RoC, fees payable to the BRLMs, fees and expenses of the legal counsels of our Company and Promoter Selling Shareholders, fees payable to the Registrar to the Offer, Escrow Collection Bank and Sponsor Bank(s) to the Offer and any other consultants, advisors or third parties in connection with the Offer, processing fee to the SCSBs for processing application forms, brokerage and selling commission payable to members of the Syndicate, Registered Brokers, RTAs and CDPs, printing and stationery expenses, advertising and marketing expenses and all other incidental and miscellaneous expenses for listing the Equity Shares on the Stock Exchanges. Other than (a) listing fees; and (b) any fee and expense not directly attributable to the Offer, including but not limited to (i) any consultant fees aimed at strengthening our Company’s finance and business process; (ii) the fees and expenses of the statutory auditors only in relation to the routine statutory audit of our Company and Subsidiaries; (iii) the expenses for any product or corporate advertisements consistent with our Company’s past practice (other than the expenses relating

Company strengths and risks

Strengths

  • - Balanced but still-developing investment profile

Disclosed risks

  • - Profit growth is weak or negative

Figures in Rs crore

Company financials

View official NSE prospectus

Profit and loss

ParticularsFY2026FY2025FY2024
Revenue43,894.8835,977.5726,905.58
EBITDA34,129.42N/A27,188.23
Profit after tax74.1871.7162.76

Balance sheet

ParticularsFY2026FY2025FY2024
Total assets6,420.458,771.867,106.93
Net worth356.73285.12212.02